Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- 11 August 2024
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8585-8595
Abstract
The presence at diagnosis, or development of, colorectal peritoneal metastases (CPM) is common in colorectal cancer. Cytoreductive surgery (CRS) and hypertKeywords
This publication has 41 references indexed in Scilit:
- Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgeryJournal of Surgical Oncology, 2023
- The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver MetastasesJournal of Gastrointestinal Surgery, 2018
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected casesTechniques in Coloproctology, 2017
- Axillary Lymph Node Involvement, a Unique Pattern of Metastasis inBRAF-Mutant Colorectal CancerJAMA Oncology, 2015
- KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastasesCancer, 2014
- Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancerEuropean Journal of Surgical Oncology, 2014
- Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancerJournal of Surgical Oncology, 2014
- Treatment of surgically resectable colorectal peritoneal metastasesBritish Journal of Surgery, 2014
- Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosisCancer, 2010
- Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis1996